JESSICA WILCOX: Open Payments
NPI 1134400732 · MOUNT VERNON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,570 in 72 payments from 21 companies in 2025. Trend: 2023 $1,387 · 2024 $1,380 · 2025 $1,570
Food & beverage: $1,570
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $246 |
| ABBVIE INC. | 16 | $237 |
| GlaxoSmithKline, LLC. | 7 | $164 |
| Novo Nordisk Inc | 7 | $151 |
| Lilly USA, LLC | 6 | $145 |
| PFIZER INC. | 4 | $92 |
| Amgen Inc. | 3 | $81 |
| Lundbeck LLC | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $59 |
| Viatris Specialty LLC | 2 | $45 |
Products named: VRAYLAR, MOUNJARO, TRELEGY ELLIPTA, BREZTRI, REXULTI, Wegovy, FARXIGA, AIRSUPRA.
Industry payments across WA — which companies pay providers there.
